
Monica Zuradelli
Advertisement
Articles by Monica Zuradelli

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026
2
Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial
3
Cellular Therapy and Antibody-Drug Conjugates Shape Day 1 of ASCO Breakthrough 2026
4
GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations
5

![TPS 25 Phase 1/2 Study of the Novel Radioligand Therapy [177Lu]Lu-NeoB Plus Capecitabine in Patients With ER+/HER2− Advanced Breast Cancer (ABC) With GRPR Expression After Progression on Prior Endocrine Therapy Plus a CDK4/6 Inhibitor for ABC](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/bb58c5f3c3692dc35c19320bb63c3df864f9b79b-1500x722.png?w=300&fit=crop&auto=format)